BOT 4.00% 36.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-69

  1. 79 Posts.
    lightbulb Created with Sketch. 12
    Although I am not a medical scientist, IMO this share price result would only be applicable if the trial showed no effect or severe adverse side effects and did not treat acne at all. The announcement does not say that at all - unless of course I am missing something. I would like to think the BOT management are preparing another announcement pronto to clarify the results. I brought more because I only see positives here excluding what appears to be an error with the USA results.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
-0.015(4.00%)
Mkt cap ! $651.6M
Open High Low Value Volume
37.5¢ 38.0¢ 36.0¢ $1.728M 4.749M

Buyers (Bids)

No. Vol. Price($)
9 220425 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 212945 8
View Market Depth
Last trade - 13.53pm 31/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.